Arcutis Biotherapeutics (NASDAQ:ARQT) Issues Quarterly Earnings Results, Beats Expectations By $0.09 EPS

Arcutis Biotherapeutics (NASDAQ:ARQT – Get Free Report) announced its earnings results on Wednesday. The company reported ($0.33) EPS for the quarter, beating analysts’ consensus estimates of ($0.42) by $0.09, Zacks reports. The business had revenue of $44.76 million during the quarter, compared to analysts’ expectations of $38.05 million. Arcutis Biotherapeutics had a negative net margin […]

Leave a Reply

Your email address will not be published.

Previous post High school football: Totino-Grace defense the key in Class 4A state quarterfinals against Hill-Murray
Next post EZGO Technologies (NASDAQ:EZGO) Trading 0.9% Higher – Time to Buy?